Growth Metrics

Organogenesis Holdings (ORGO) Total Debt (2017 - 2024)

Organogenesis Holdings has reported Total Debt over the past 8 years, most recently at $62.1 million for Q3 2024.

  • For Q3 2024, Total Debt fell 8.11% year-over-year to $62.1 million; the TTM value through Sep 2024 reached $62.1 million, down 8.11%, while the annual FY2023 figure was $66.2 million, 6.41% down from the prior year.
  • Total Debt for Q3 2024 was $62.1 million at Organogenesis Holdings, down from $63.5 million in the prior quarter.
  • Over five years, Total Debt peaked at $73.9 million in Q3 2021 and troughed at $11.7 million in Q1 2020.
  • A 5-year average of $59.3 million and a median of $66.2 million in 2023 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: crashed 74.07% in 2020 and later soared 412.14% in 2021.
  • Year by year, Total Debt stood at $26.7 million in 2020, then soared by 175.35% to $73.4 million in 2021, then dropped by 3.62% to $70.8 million in 2022, then decreased by 6.41% to $66.2 million in 2023, then decreased by 6.21% to $62.1 million in 2024.
  • Business Quant data shows Total Debt for ORGO at $62.1 million in Q3 2024, $63.5 million in Q2 2024, and $64.9 million in Q1 2024.